The BRIDGE Rehabilitation Trial

NCT03102814 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 381

Last updated 2020-03-02

No results posted yet for this study

Summary

The main aim of this multi-centre stepped wedge randomized controlled trial is to improve the quality, professional practice and cost-effective utilization of health care resources by evaluating if a new rehabilitation program aimed at bridging gaps in rehabilitation across levels of care may increase and/or prolong the effect of rehabilitation.

Conditions

  • Musculoskeletal Disease

Interventions

BEHAVIORAL

Current rehabilitation

The control group will receive the rehabilitation currently offered at each of the participating centers.

BEHAVIORAL

The BRIDGE program

The experimental group will additionally receive the BRIDGE program, which comprises motivational interviewing, structured goal-setting, tailored follow-up, plans for self-management, and individualised written feedback that participants can use to monitor their progress and share with important care givers.

Sponsors & Collaborators

  • Sørlandet Hospital

    collaborator UNKNOWN
  • Vikersund Rehabilitation Centre

    collaborator UNKNOWN
  • Muritunet Rehabilitation Centre

    collaborator UNKNOWN
  • Valnesfjord Rehabilitation Centre

    collaborator UNKNOWN
  • Meråker Rehabilitation Centre

    collaborator UNKNOWN
  • Rehab Vest Rehabilitation Centre

    collaborator UNKNOWN
  • Lillehammer Rheumatism Hospital

    collaborator UNKNOWN
  • Haugesund Rheumatism Hospital

    collaborator OTHER
  • National Resource Center for Rehabilitation in Rheumatology

    lead OTHER

Principal Investigators

  • Tore K Kvien, PhD · Diakonhjemmet Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-15
Primary Completion
2019-08-30
Completion
2019-08-30

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03102814 on ClinicalTrials.gov